HomeAVBP • NASDAQ
add
Arrivent Biopharma Inc
Previous close
$28.99
Day range
$28.72 - $29.47
Year range
$14.35 - $30.99
Market cap
977.35M USD
Avg Volume
394.32K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 25.70M | 13.78% |
Net income | -21.87M | -1.42% |
Net profit margin | — | — |
Earnings per share | -0.65 | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 298.67M | 63.36% |
Total assets | 308.86M | 55.33% |
Total liabilities | 12.20M | -4.82% |
Total equity | 296.66M | — |
Shares outstanding | 33.59M | — |
Price to book | 3.28 | — |
Return on assets | -20.18% | — |
Return on capital | -20.89% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -21.87M | -1.42% |
Cash from operations | -19.09M | -121.79% |
Cash from investing | — | — |
Cash from financing | 363.00K | 1,915.00% |
Net change in cash | -18.72M | 44.32% |
Free cash flow | -12.93M | — |
About
Founded
2021
Headquarters
Website
Employees
40